When Is a Second-Level or External Appeal Worth Pursuing After a First-Level Appeal Fails?

What Decides Whether a Denial Is Worth a Second Appeal

The goal is a clear, evidence-based call on every first-level loss: escalate the ones with real overturn odds and real dollars, close the ones that are truly dead, and get better at telling them apart every month. Here is what does that, move by move.

1. Map the Appeal Levels Available for Each Payer and Claim Type

You cannot escalate an appeal you did not know existed. Most payers offer a first-level review, a second-level review often with a peer-to-peer option, and an external or independent review beyond that, and the levels and deadlines differ by payer, plan, and whether the claim is commercial, Medicare Advantage, or Medicaid managed care. Before writing anything off, the specialist confirms exactly which levels and windows apply to this denial. The write-off that feels final is often just the end of level one, with two more levels and a real deadline still open.

2. Decide What to Escalate on Overturn Odds and Dollars, Not Gut Feel

Not every first-level loss is worth a second appeal, and the way to tell is data, not instinct. Escalate on two things: the odds of overturn for this denial reason, payer, and level, and the dollar value of the claim. A high-value claim with a denial reason that historically overturns on escalation is an easy yes; a small claim with a truly correct denial is a clean close. Reporting on authorization denials shows the vast majority of appealed Medicare Advantage denials get overturned even though only a small fraction are ever appealed, which means the practices that escalate on evidence are collecting money the rest are writing off.

3. Build the Escalation to Answer Why the First Appeal Failed

A second-level appeal that just resends the first one loses again. The escalation has to answer the specific reason the first appeal was denied: the criteria the reviewer cited, the documentation they ruled insufficient, the guideline they applied. That means reading the first-level denial to its actual rationale, closing that exact gap with new or better-organized evidence, and, when a peer-to-peer is available, putting the ordering physician in front of a medical reviewer with the clinical case ready. Each level is a new argument, not a louder version of the last one.

4. Track Overturn Rates by Level and Payer So the Call Gets Smarter

The reason practices never escalate is that they never learn. Track every appeal by level, payer, denial reason, and outcome, and within a few months you can see exactly which second-level and external appeals are worth filing and which are not. That overturn data turns escalation from a gamble into a routine business decision: this payer folds at second level on this denial reason, that one only moves at external review, this reason is a waste of time past level one. Without the tracking, every first-level loss looks equally hopeless, which is precisely why the recoverable ones get written off with the rest.

5. Hand Multi-Level Appeals to a Dedicated Team

Practices that stop writing off recoverable denials do it by handing appeal escalation to a dedicated team: remote specialists who map the levels, decide what to escalate on evidence, build each appeal to answer why the last one failed, and track overturn rates by payer, live in 1 to 2 weeks. The billing lead stops closing accounts at level one out of habit, a trained backup covers every gap, and the appeals that were quietly worth pursuing start getting pursued. Below is what it sounds like when nobody owns this yet, in billing teams’ own words.

Why This Keeps Happening

If escalation pays off, why do practices stop at level one? Because the workflow was built to appeal once and close, and nobody tracks what that habit costs. A lost first-level appeal feels final, so the account gets written off, and because there is no overturn-rate reporting by level or payer, the practice never learns that the loss was recoverable. Every first-level denial looks equally dead, so the genuinely recoverable ones get closed alongside the truly correct ones. Rebuilding that workflow so a first-level loss triggers an evidence-based escalation decision instead of an automatic write-off is exactly what disciplined revenue cycle management is built to do.

The numbers make the case that most practices never see. Reporting on authorization denials found that more than 80 percent of appealed Medicare Advantage denials were fully or partially overturned, yet only about 11.5 percent of denials were appealed at all, a pattern the federal Office of Inspector General has documented across multiple years, with skilled nursing facility denials approved on appeal the vast majority of the time. That gap, denials that overturn at high rates but are almost never escalated, is money sitting on the table, and the practices leaving it there are the ones with no second-level workflow. Closing that gap is exactly what an AI medical billing workflow with human oversight is built to do.

And the cost of stopping at level one compounds quietly. Every recoverable denial written off is revenue the practice earned and then surrendered, but the deeper cost is the blindness: with no overturn tracking, the practice cannot see which payers fold at second level, which denial reasons are worth external review, or how much a persistence workflow would collect. So it keeps making the same call, appeal once and close, on denials that a second push would overturn. The lost revenue on any one claim is real. The habit of never learning which losses were winnable is what makes it a pattern.

Most groups have already tried the obvious fixes before they talk to anyone. Each one fails the same way: the work lands back on the practice. The pattern, in one table:

The Solution

So what does “someone whose whole job it is” look like after a first-level loss? The specialist starts where the practice usually stops: mapping which appeal levels and deadlines are still open, first-level, second-level with any peer-to-peer, external or independent review, so nothing gets written off just because it feels final. Then they decide what to escalate on evidence, weighing the overturn odds for that denial reason and payer against the claim value, instead of closing everything by habit. Most recoverable losses are a persistence-and-evidence problem, and that is exactly what dedicated denial management and appeals support is built to solve, before a winnable denial becomes a write-off.

When a denial is worth escalating, the specialist builds the appeal to answer why the last one failed, not to resend it. They read the first-level denial to its actual rationale, close that exact gap with better evidence, and when a peer-to-peer is on the table, put the physician in front of the reviewer with the clinical case ready. And they track every appeal by level, payer, reason, and outcome, so within a few months the practice can see which second-level and external appeals are worth filing and stop guessing.

Behind all of it, AI drafts the first pass and a credentialed human verifies. The workflow flags which levels remain open, surfaces the overturn odds, and assembles the escalation packet; a person confirms the argument answers the prior denial and owns the peer-to-peer and the escalation call. Every security control that protects the clinical and claim data moving through that process is documented and auditable, and the whole approach is described on our HIPAA and security page, because moving chart documentation through an appeals workflow is only safe when the controls are real.

Who Actually Does This Work

Fair question: why would an outsourced team win your second-level appeals better than your own staff? Because reading a denial to its rationale, knowing each payer’s appeal levels, and building an escalation that answers the prior loss is their entire day, not the thing they abandon at level one when the queue gets busy. The people working your appeals are credentialed medical professionals: overseas-trained physicians, US-licensed nurses and pharmacists, and PharmDs, all trained in US denial and appeals workflows. They know which payers fold at second level on which denial reasons, how to build an external-review packet, and how to run a peer-to-peer so the physician wins it. That is not a task you hand to whoever is free; it is a specialty.

We are not a call center. We are a clinical operations partner, a healthcare BPO built on dedicated virtual staff: 500+ credentialed professionals, 24/7 coverage, and the AI-first-pass plus human-verify workflow you just read about behind every one of them. A typical practice is live in 1 to 2 weeks, at up to 70% below the cost of hiring locally, and no one on our side goes out without a trained backup already inside your workflow, so a winnable appeal never gets written off because the one person who tracks overturns is on vacation.

And the security piece your compliance officer will ask about: we are audited to SOC 2 Type II with zero exceptions and certified for ISO/IEC 27001:2022, HIPAA, and GDPR, with zero breaches in eight years. Every workstation runs inside a secure enclave on US-based servers, with screen captures and downloads blocked by policy, so PHI never sits on someone’s home laptop. Every client account carries a $5M E&O and cyber liability policy and a BAA signed before any work starts; the full detail lives in our HIPAA and security posture.

Put the routine and the people together, and a specific list of things simply stops happening.

How We Permanently Fix the Process

A person alone is not the fix, and neither is a bot alone. The fix is a documented multi-level appeal workflow: which appeal levels and deadlines each payer offers by claim type, the overturn odds by denial reason and level, how to build a second-level or external packet that answers the prior loss, and how overturn rates are tracked and reported, all written down and worked the same way every time. Before we take a single appeal for a new practice, we chart your first-level losses by payer and denial reason so we can see which write-offs were probably recoverable, and we build the workflow against that, not against a generic template.

From there the workflow becomes a living playbook rather than tribal knowledge in one biller’s head. It records each payer’s appeal levels and windows, the overturn history by reason and level, how to close the specific gap a first-level denial cited, and the escalation path to external review. It is written down, kept current as the overturn data grows, and owned by the team. When your specialist is out, a trained backup works the same playbook the same way, so a winnable denial never gets closed because the one person who knew it was worth escalating was off that day.

That is the difference between working this month’s first-level appeals and fixing the process for good, and it is what a dedicated revenue cycle management partner actually buys you. A biller leaving used to mean the appeal habit reset to appeal-once-and-close and the overturn data reset to nothing. Under this model the workflow keeps running, the playbook and the overturn history stay, the backup steps in, and a first-level loss stops being an automatic write-off.

The Whole Thing in Four Sentences

A second-level or external appeal is worth pursuing far more often than practices assume, because denials escalated past level one are overturned at high rates while most are never appealed that far. Writing off every first-level loss, resending the same appeal at second level, and deciding what to escalate by gut feel all fail the same way, and none of them ever learn from the outcome. The fix is to map the appeal levels for each payer, decide what to escalate on overturn odds and claim value, build each escalation to answer why the last one failed, and track overturn rates by level and payer so the call gets smarter every month. A multi-provider internal medicine group runs exactly this model with us today, names withheld, no patient data shown.

If you want to check us out before talking to anyone: our security posture is independently auditable, we are an MGMA 2026 Corporate Member, and 800+ providers run back office work with us.

Ready to stop writing off winnable denials? Try us risk free: two weeks, your real first-level losses, dedicated specialists escalating on evidence and tracking the overturns, and if it does not earn the handoff, you walk away. From here down is the sales part, and it is short: here is exactly what it costs.

Written By

Dan Nandan

Founder and CEO, Staffingly, Inc. · Piscataway, NJ

Dan Nandan has spent 25+ years in IT consulting and healthcare BPO, was among the first in the US to build an RPO/BPO delivery network in India, and has been featured in Computerworld. He runs the operations and the dedicated virtual teams behind the workflows on this page; the team-voice answers above come from the remote specialists who work them every day.

Connect on LinkedIn

Where the Claims on This Page Come From